Arcus Biosciences, Inc. (RCUS)

22.71 -0.03 (-0.13%) USD  |  NYSE  |  Jan 14, 10:13
More

Arcus Biosciences Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
Janux Therapeutics, Inc. Upgrade